Topics

Alnylam Highlights Progress on Global Market Access for ONPATTRO (patisiran)

16:00 EDT 30 Apr 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
− In the United States, Company Completes Tenth Value-Based Agreement with Commercial Payers, and Achieves Confirmed Access to ONPATTRO for Greater than 90 Percent of Covered Lives – − In Europe, Company Achieves ...

Other Sources for this Article

Alnylam Pharmaceuticals, Inc
Christine Regan Lindenboom
(Investors and Media)
617-682-4340

Josh Brodsky
(Investors)
617-551-8276

NEXT ARTICLE

More From BioPortfolio on "Alnylam Highlights Progress on Global Market Access for ONPATTRO (patisiran)"

Quick Search

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...